These findings indicate that Nrf2 KO altered the fecal bacterial composition in the female WT control group (but not in the WT male control group), as well as in the male and female WT AOM/DSS-treated groups (Figure 2). The gene discussed is NFE2L2; the disease is infectious otitis media.